标题
Inflammasome activation by SARS-CoV-2 and its participation in COVID-19 exacerbation
作者
关键词
-
出版物
CURRENT OPINION IN IMMUNOLOGY
Volume 84, Issue -, Pages 102387
出版商
Elsevier BV
发表日期
2023-09-12
DOI
10.1016/j.coi.2023.102387
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CASP4/11 Contributes to NLRP3 Activation and COVID-19 Exacerbation
- (2023) Tamara S Rodrigues et al. JOURNAL OF INFECTIOUS DISEASES
- Inflammasome activation in infected macrophages drives COVID-19 pathology
- (2022) Esen Sefik et al. NATURE
- FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation
- (2022) Caroline Junqueira et al. NATURE
- Caspase-4/11 exacerbates disease severity in SARS–CoV-2 infection by promoting inflammation and immunothrombosis
- (2022) Mostafa M. Eltobgy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The immunology and immunopathology of COVID-19
- (2022) Miriam Merad et al. SCIENCE
- SARS-CoV-2 Causes Lung Inflammation through Metabolic Reprogramming and RAGE
- (2022) Charles N. S. Allen et al. Viruses-Basel
- Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19
- (2022) Eugenio Damaceno Hottz et al. Blood Advances
- Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection
- (2022) Letícia de Almeida et al. Science Advances
- SARS-CoV-2 infection in K18-ACE2 transgenic mice replicates human pulmonary disease in COVID-19
- (2021) Victor M. Arce et al. Cellular & Molecular Immunology
- Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity
- (2021) Héloïse Flament et al. NATURE IMMUNOLOGY
- Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice
- (2021) Jianxiong Zeng et al. EBioMedicine
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study
- (2020) Yi Han et al. Aging-US
- Characterization of the Inflammatory Response to Severe COVID-19 Illness
- (2020) Oliver J McElvaney et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2 Infection
- (2020) Gregory Brett Moreau et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis
- (2020) Ana Campos Codo et al. Cell Metabolism
- The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation
- (2020) Alexander Hooftman et al. Cell Metabolism
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
- (2020) W. Joost Wiersinga et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
- (2020) Ying Chi et al. JOURNAL OF INFECTIOUS DISEASES
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- (2020) Carolina Lucas et al. NATURE
- Inflammasome formation in the lungs of patients with fatal COVID-19
- (2020) Stefano Toldo et al. INFLAMMATION RESEARCH
- Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
- (2020) Tamara S. Rodrigues et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice
- (2020) Fatai S. Oladunni et al. Nature Communications
- Leishmania Lipophosphoglycan Triggers Caspase-11 and the Non-canonical Activation of the NLRP3 Inflammasome
- (2019) Renan V.H. de Carvalho et al. Cell Reports
- HIF1α-Induced Glycolysis Metabolism Is Essential to the Activation of Inflammatory Macrophages
- (2017) Ting Wang et al. MEDIATORS OF INFLAMMATION
- Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death
- (2017) Jianjin Shi et al. TRENDS IN BIOCHEMICAL SCIENCES
- Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
- (2016) Rudragouda Channappanavar et al. Cell Host & Microbe
- An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells
- (2016) Ivan Zanoni et al. SCIENCE
- Mechanism and Regulation of NLRP3 Inflammasome Activation
- (2016) Yuan He et al. TRENDS IN BIOCHEMICAL SCIENCES
- The hierarchical structural architecture of inflammasomes, supramolecular inflammatory machines
- (2015) Arthur V Hauenstein et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Caspase-11 activates a canonical NLRP3 inflammasome by promoting K+efflux
- (2015) Sebastian Rühl et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Caspase-4 mediates non-canonical activation of the NLRP3 inflammasome in human myeloid cells
- (2015) Jonathan L. Schmid-Burgk et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase-4 and caspase-5
- (2015) Paul J. Baker et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Non-canonical inflammasome activation targets caspase-11
- (2011) Nobuhiko Kayagaki et al. NATURE
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started